Schade, David S.

Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study

Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism

Folate and B Vitamins ResearchPorphyrin Metabolism and Disorders

Cited by 536

Prehepatic Insulin Production in Man: Kinetic Analysis Using Peripheral Connecting Peptide Behavior*

EATON, R. P., ALLEN, R. C., SCHADE, D. S., ERICKSON, K. M., & STANDEFER, J. (1980) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesDiabetes Management and Research

Cited by 363

Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.

Boyle, P. J., Justice, K., Krentz, A. J., Nagy, R. J., & Schade, D. S. (1993) · The Journal of Clinical Endocrinology & Metabolism

Poisoning and overdose treatmentsDiabetes Treatment and Management

Cited by 125

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

Purnell, J. Q., Braffett, B. H., Zinman, B., Gubitosi-Klug, R. A., Sivitz, W., Bantle, J. P., Ziegler, G., Cleary, P. A., Brunzell, J. D., DCCT/EDIC Research Group, et al. (2017) · Diabetes Care

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 120

Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey

Lindeman, R. D., Romero, L. J., Schade, D. S., Wayne, S., Baumgartner, R. N., & Garry, P. J. (2003) · Thyroid

Thyroid Disorders and TreatmentsFolate and B Vitamins Research

Cited by 100

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Insulins

Burge, M. R., & Schade, D. S. (1997) · Endocrinology and Metabolism Clinics of North America

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 48

An Observational Study of the Equivalence of Age and Duration of Diabetes to Glycemic Control Relative to the Risk of Complications in the Combined Cohorts of the DCCT/EDIC Study

Bebu, I., Braffett, B. H., Schade, D., Sivitz, W., Malone, J. I., Pop-Busui, R., Lorenzi, G. M., Lee, P., Trapani, V. R., Wallia, A., et al. (2020) · Diabetes Care

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 29

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Diabetes and the Affordable Care Act

Burge, M. R., & Schade, D. S. (2014) · Diabetes Technology & Therapeutics

Healthcare Policy and ManagementDiabetes Management and Research

Cited by 21

Metabolic Effects of 2 Days of Strict Bed Rest

Duran-Valdez, E., de Serna, D. G., Schneider, S., Amorim, F., Burge, M., & Schade, D. S. (2008) · Endocrine Practice

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 7